openPR Logo
Press release

Infasurf Market Forecast 2025-2034: Analysing Major Trends, Opportunities, and Growth Drivers

03-26-2025 05:47 AM CET | Health & Medicine

Press release from: The Business Research Company

Infasurf

Infasurf

What market dynamics are playing a key role in accelerating the growth of the infasurf market?
The escalation in the number of premature births is projected to fuel the growth of the infasurf market in the near future. A premature or preterm birth is characterized by a delivery before the 37th week of gestation, unlike a typical full-term birth unfolding around the 40th week, which could result in a host of health issues for the newborn like respiratory complications, developmental hindrances, and a greater probability of enduring disabilities. The surge in premature births could be attributed to a number of factors such as increasing maternal age, a spike in multiple pregnancies courtesy of assisted reproductive technologies, and the consequences of chronic health issues and infections during pregnancy. Infasurf (calfactant) is typically delivered directly into the lungs of premature babies to fend off or alleviate respiratory distress syndrome (RDS) by reducing surface tension and enhancing lung function. As an example, a study from the University of Bristol, a public research university in the UK, revealed in October 2024 that about one out of every 13 births is preterm, amounting to over 50,000 cases every year. In spite of preventive strategies for women at high risk, the rate of preterm births continues to escalate. Furthermore, as per the March of Dimes, a non-profit organization based in the US, in March 2024, the US reported 373,902 preterm births in 2023 which constituted 10.4% of all live births. Thus, the soaring rate of premature births is augmenting the growth of the infasurf market.

Get Your Infasurf Market Report Here:
https://www.thebusinessresearchcompany.com/report/infasurf-global-market-report

How will the growth rate of the infasurf market shape industry trends by 2034?
In recent years, the infasurf market has experienced a steady growth rate of XX% (HCAGR). The market size is predicted to rise from an impressive $XX million in 2024 to an even higher $XX million in 2025, demonstrating a compound annual growth rate (CAGR) of XX%. This substantial growth in the historic period is due to several contributing factors including an uptick in premature births, enhancements in healthcare infrastructure, increased awareness about respiratory conditions, a surge in birth rates and sustained government efforts to decrease infant death rates.

In the coming years, the infasurf market is projected to witness a growth of XX (FCAGR). By 2029, its worth is predicted to reach $XX million, growing at a compound annual growth rate (CAGR) of XX%. This growth over the forecast period is largely due to factors such as the rising utilization of personalized medicine, escalating air pollution levels, increasing occurrence of neonatal respiratory illnesses, heightened emphasis on preventive care, and swift urbanization. The major trends within the forecast period consist of X*XX.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20100&type=smp

Which primary segments of the infasurf market are driving growth and industry transformations?
The infasurf market covered in this report is segmented -

1) By Patient Demographics: Premature Infants, Full-Term Infants, Age Groups
2) By Distribution Channel: Hospitals, Specialty Clinics, Online Pharmacies, Pharmacies
3) By Application: Neonatal Respiratory Distress Syndrome, Other Respiratory Conditions

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20100

Which geographical regions are pioneering growth in the infasurf market?
North America was the largest region in the infasurf market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the infasurf market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Who are the influential players reshaping the infasurf market landscape?
Major companies operating in the infasurf market include ONY Biotech Inc.

Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/customise?id=20100&type=smp

What Is Covered In The Infasurf Global Market Report?

•Market Size Forecast: Examine the infasurf market size across key regions, countries, product categories, and applications.
•Segmentation Insights: Identify and classify subsegments within the infasurf market for a structured understanding.
•Key Players Overview: Analyze major players in the infasurf market, including their market value, share, and competitive positioning.
•Growth Trends Exploration: Assess individual growth patterns and future opportunities in the infasurf market.
•Segment Contributions: Evaluate how different segments drive overall growth in the infasurf market.
•Growth Factors: Highlight key drivers and opportunities influencing the expansion of the infasurf market.
•Industry Challenges: Identify potential risks and obstacles affecting the infasurf market.
•Competitive Landscape: Review strategic developments in the infasurf market, including expansions, agreements, and new product launches.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Infasurf Market Forecast 2025-2034: Analysing Major Trends, Opportunities, and Growth Drivers here

News-ID: 3937739 • Views:

More Releases from The Business Research Company

Segment Evaluation and Major Growth Areas in the Personalized Testing and Supplements Market
Segment Evaluation and Major Growth Areas in the Personalized Testing and Supple …
The personalized testing and supplements sector is gaining remarkable traction, driven by advancements in technology and a rising consumer focus on tailored health solutions. As more individuals seek customized wellness options, this market is set to experience substantial expansion in the coming years. Here's an in-depth look at its current valuation, key players, significant trends, and the main market segments shaping its future. Market Valuation and Expansion Forecast for Personalized Testing
Top Players and Market Competition in the Skin Microbiome Industry
Top Players and Market Competition in the Skin Microbiome Industry
The skin microbiome market is emerging as a significant area of interest due to growing awareness about the critical role of skin health and innovative skincare technologies. As research advances and consumer preferences shift towards more natural and science-backed products, this market is set to undergo substantial growth. Let's explore the current market size, key players, driving factors, and upcoming trends shaping the skin microbiome industry. Projected Expansion in the Skin
Key Strategic Developments and Emerging Changes Shaping the Upadacitinib Market Landscape
Key Strategic Developments and Emerging Changes Shaping the Upadacitinib Market …
The upadacitinib market is poised for significant expansion over the coming years, driven by advances in treatment options and increasing awareness of autoimmune diseases. This report delves into the market's current size, key drivers, major players, and the emerging trends shaping its future trajectory. Steady Growth Expected in Upadacitinib Market Size Through 2029 The market for upadacitinib is projected to reach $2.54 billion by 2029, growing at a robust compound annual
Analysis of Key Market Segments Driving the Alzheimer's Disease Diagnostic Market
Analysis of Key Market Segments Driving the Alzheimer's Disease Diagnostic Marke …
The Alzheimer's disease diagnostic sector is rapidly evolving as advancements in technology and healthcare infrastructure open new possibilities for early detection and personalized treatment. With rising awareness and innovative approaches, this market is poised for significant growth in the coming years. Let's explore the current market size, key drivers, leading companies, and emerging trends that are shaping this critical healthcare field. Projected Market Size and Growth Trends in Alzheimer's Disease Diagnostics

All 5 Releases


More Releases for Infasurf

Global Infasurf Market Outlook 2025-2034: Trends, Innovations, And Future Outloo …
"The Infasurf Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]. What Is the Infasurf Market Size and Projected Growth Rate? In recent times, the infasurf market has experienced a XX (HCAGR). From 2024 to 2025, it is projected to flourish from $XX million to $XX million,
Prominent Infasurf Market Driver for 2025: Rising Prevalence Of Premature Births …
What Are the Market Size and Growth Forecast for the Infasurf Market? The size of the Infasurf market has seen an $XX in the past few years. The market value is predicted to rise from $XX million in 2024 to $XX million in 2025, demonstrating a compound annual growth rate (CAGR) of $XX%. Key factors contributing to the historic growth include a surge in premature birth rates, an enhanced healthcare infrastructure,
Surfactant in the Treatment of Respiratory Distress Syndrome
FOR IMMEDIATE RELEASE New York,NY:Respiratory distress syndrome (RDS) is one of the most common lung disorders in premature infants. RDS is a breathing disorder that affects about 10 in 100 premature infants in the United States. The earlier an infant is born, the less developed the lungs are and the higher the risk of RDS. The main cause of respiratory distress syndrome is a lack of surfactant in the lungs, which is
The Role of Neonatal Nurse Practitioners in the Treatment of Infant Respiratory …
FOR IMMEDIATE RELEASE New York, U.S.:Newborns who are diagnosed with infant respiratory distress syndrome (RDS) are often cared for by neonatal nurse practitioners in a neonatal intensive care unit (NICU). Infant respiratory distress syndrome is characterized by a lack of surfactant in the lungs. Surfactant is a naturally occurring substance that coats the lungs and helps them to function properly. Infants who are born prematurely -- that is, born at least
Treating Infant Respiratory Distress Disorders with Pulmonary Surfactants
FOR IMMEDIATE RELEASE New York, U.S.:Infants who experience respiratory distress disorders are commonly treated with pulmonary surfactants. Respiratory distress syndrome (RDS) is a condition in which the lungs are not fully developed and the infant has trouble breathing on his or her own. This is due to insufficient amounts of surfactant, which is a naturally occurring substance that coats the lungs and allows them to function properly. Infants who are born
Respiratory Distress Syndrome ("Blue Baby Syndrome") in Infants
FOR IMMEDIATE RELEASE New York, U.S.: Infants who are born prematurely are sometimes diagnosed with respiratory distress syndrome (RDS), also known as "blue baby syndrome". The condition is caused by a lack of surfactant, which is a naturally occurring substance that helps the lungs function properly. Surfactant is usually produced just a few weeks before birth. When premature infants -- born around six weeks before their due date -- don' t